Ads
related to: gilead- Treatment Costs & Savings
See If You Are Eligible For Savings
Or Assistance Programs.
- Helpful Patient Tools
Find Information For Patients Here.
Visit The Official Patient Website.
- Get Treatment Resources
See Tools Specifically For Patients
About Dosing, Savings And More.
- Important Safety Info
Learn About Possible Side Effects
And View Important Safety Info.
- HIV Treatment Injectable
Learn About A Treatment Option
And Find More Info Online Today.
- Talk To Your Doctor
Find Info & Resources To Speak With
Your Doctor About HIV-1 Treatment.
- Treatment Costs & Savings
Search results
Gilead (GILD), RCUS Announce Data From Colorectal Cancer Study
Zacks via Yahoo Finance· 5 hours agoGilead Sciences, Inc. GILD and partner Arcus Biosciences, Inc. RCUS announce new data from Cohort B...
Hedge Funds are Bullish on This Gene Therapy Stock
Insider Monkey via Yahoo Finance· 3 hours agoWe recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we discuss Gilead Sciences, Inc. (NASDAQ:GILD), which is...
Top Stock Reports for NextEra Energy, BP & Gilead Sciences
Zacks via Yahoo Finance· 6 hours agoToday's Research Daily features new research reports on 16 major stocks, including NextEra Energy,...
Pharma firm urged to share new 'game-changer' HIV drug
AFP via Yahoo News· 4 days agoMore than 300 politicians, health experts and celebrities called Thursday for US pharmaceutical...
Paulson Wealth Management Inc. Grows Stake in Gilead Sciences, Inc. (NASDAQ:GILD)
ETF DAILY NEWS· 14 hours agoPaulson Wealth Management Inc. grew its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 5.3% in the 4th quarter, according to its most recent 13F filing with ...
After Disappointing Bladder Cancer Data, Gilead Announces Encouraging Data From Gastric, Colorectal...
Benzinga· 7 hours agoGilead Sciences and Arcus Biosciences report sustained efficacy and safety in the Phase 2 EDGE-Gastric study for upper GI cancers, showing improved progression-free survival ...
Gilead’s Trodelvy misses goal in bladder cancer study
BioPharma Dive via Yahoo Finance· 4 days agoTreatment didn’t significantly improve overall survival in the trial, a finding that one analyst...
Gilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of...
Morningstar· 1 day agoGilead and Arcus Announce EtrumadenantPlus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal Cancer – In Cohort B of the ARC ...
Gilead's Trodelvy fails bladder cancer trial, modestly extends lung cancer survival
Reuters via Yahoo News· 3 days ago(Reuters) -Gilead Sciences' Trodelvy failed to improve survival for patients with advanced bladder...
Gilead's Trodelvy fails to meet main goal in late-stage cancer study
Reuters via AOL· 4 days agoShares of Gilead fell 3.3% in extended trade after the company said the drug did not meet the main...
